J7173 – Injection, concizumab-mtci, 0.5 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ7173
- Long description
- Injection, concizumab-mtci, 0.5 mg
- Short description
- Inj. concizumab-mtci, 0.5 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- October 1, 2025
- Last change
- October 1, 2025 – No change
Frequently asked questions
What is HCPCS code J7173?
J7173 is a HCPCS Level II code for injection, concizumab-mtci, 0.5 mg.
Does Medicare cover J7173?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J7121 – 5% dextrose in lactated ringers infusion, up to 1000 cc
- J7131 – Hypertonic saline solution, 1 ml
- J7165 – Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity
- J7168 – Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
- J7169 – Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg
- J7170 – Injection, emicizumab-kxwh, 0.5 mg
- J7171 – Injection, adamts13, recombinant-krhn, 10 iu
- J7172 – Injection, marstacimab-hncq, 0.5 mg
- J7174 – Injection, fitusiran, 0.04 mg
- J7175 – Injection, factor x, (human), 1 i.u.
- J7176 – Injection, human fibrinogen - chmt (fesilty), 1 mg
- J7177 – Injection, human fibrinogen concentrate (fibryga), 1 mg
- J7178 – Injection, human fibrinogen concentrate, not otherwise specified, 1 mg
- J7179 – Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco
- J7180 – Injection, factor xiii (antihemophilic factor, human), 1 i.u.
- J7181 – Injection, factor xiii a-subunit, (recombinant), per iu
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.